Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2016

01-09-2016 | Original Article – Cancer Research

Distinct functional domains of PNMA5 mediate protein–protein interaction, nuclear localization, and apoptosis signaling in human cancer cells

Authors: Yong Hoi Lee, Siew Wai Pang, Chit Laa Poh, Kuan Onn Tan

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2016

Login to get access

Abstract

Purpose

Members of paraneoplastic Ma (PNMA) family have been identified as onconeuronal antigens, which aberrant expressions in cancer cells of patients with paraneoplastic disorder (PND) are closely linked to manifestation of auto-immunity, neuro-degeneration, and cancer. The purpose of present study was to determine the role of PNMA5 and its functional relationship to MOAP-1 (PNMA4) in human cancer cells.

Methods

PNMA5 mutants were generated through deletion or site-directed mutagenesis and transiently expressed in human cancer cell lines to investigate their role in apoptosis, subcellular localization, and potential interaction with MOAP-1 through apoptosis assays, fluorescence microscopy, and co-immunoprecipitation studies, respectively.

Results

Over-expressed human PNMA5 exhibited nuclear localization pattern in both MCF-7 and HeLa cells. Deletion mapping and mutagenesis studies showed that C-terminus of PNMA5 is responsible for nuclear localization, while the amino acid residues (391KRRR) within the C-terminus of PNMA5 are required for nuclear targeting. Deletion mapping and co-immunoprecipitation studies showed that PNMA5 interacts with MOAP-1 and N-terminal domain of PNMA5 is required for interaction with MOAP-1. Furthermore, co-expression of PNMA5 and MOAP-1 in MCF-7 cells significantly enhanced chemo-sensitivity of MCF-7 to Etoposide treatment, indicating that PNMA5 and MOAP-1 interact synergistically to promote apoptotic signaling in MCF-7 cells.

Conclusions

Our results show that PNMA5 promotes apoptosis signaling in HeLa and MCF-7 cells and interacts synergistically with MOAP-1 through its N-terminal domain to promote apoptosis and chemo-sensitivity in human cancer cells. The C-terminal domain of PNMA5 is required for nuclear localization; however, both N-and C-terminal domains of PNMA5 appear to be required for pro-apoptotic function.
Literature
go back to reference Cui T, Hurtig M, Elgue G et al (2010) Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors. PLoS ONE. doi:10.1371/journal.pone.0016010 Cui T, Hurtig M, Elgue G et al (2010) Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors. PLoS ONE. doi:10.​1371/​journal.​pone.​0016010
go back to reference Dalmau J, Gultekin SH, Voltz R et al (1999) Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 122:27–39CrossRefPubMed Dalmau J, Gultekin SH, Voltz R et al (1999) Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 122:27–39CrossRefPubMed
go back to reference Gil J, Yamamoto H, Zapata JM et al (1999) Impairment of the proapoptotic activity of BAX by missense mutations found in gastrointestinal cancers. Cancer Res 59:2034–2037PubMed Gil J, Yamamoto H, Zapata JM et al (1999) Impairment of the proapoptotic activity of BAX by missense mutations found in gastrointestinal cancers. Cancer Res 59:2034–2037PubMed
go back to reference Schuller M, Jenne D, Voltz R (2005) The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. J Neuroimmunol 169:172–176CrossRefPubMed Schuller M, Jenne D, Voltz R (2005) The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. J Neuroimmunol 169:172–176CrossRefPubMed
go back to reference Yamamoto T, Tsuji S (2010) Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis. Brain Nerve 62:838–851PubMed Yamamoto T, Tsuji S (2010) Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis. Brain Nerve 62:838–851PubMed
go back to reference Yamamoto H, Itoh F, Fukushima H et al (1999) Frequent Bax frameshift mutations in gastric cancer with high but not low microsatellite instability. J Exp Clin Cancer Res 18:103–106PubMed Yamamoto H, Itoh F, Fukushima H et al (1999) Frequent Bax frameshift mutations in gastric cancer with high but not low microsatellite instability. J Exp Clin Cancer Res 18:103–106PubMed
Metadata
Title
Distinct functional domains of PNMA5 mediate protein–protein interaction, nuclear localization, and apoptosis signaling in human cancer cells
Authors
Yong Hoi Lee
Siew Wai Pang
Chit Laa Poh
Kuan Onn Tan
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2016
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2205-5

Other articles of this Issue 9/2016

Journal of Cancer Research and Clinical Oncology 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.